Deal Announcement


DC Advisory acted as exclusive financial advisor to UCB S.A. on the divestment of its subsidiary UCB Innere Medizin to Paragon Partner

01 Jul 2018

UCB Innere Medizin (“Innere Medizin”), which has been operating as a separate business entity since March 2016, has successfully promoted pharmaceutical products in Germany for many years, mainly to general practitioners and specialists in the internal medicine area for cardiovascular and respiratory diseases.

In line with its global strategy, this move will further enable UCB to focus on its core activities in the fields of neurology, immunology and bone diseases to provide the best solutions to patients suffering from severe diseases.

Paragon Partners (“Paragon”) will manage Innere Medizin as a stand-alone company and will assume the entire staff of approximately 200 employees. Paragon plans to continue the current, successful business model and strategy, and plans to further develop and grow the business. Innere Medizin will operate under a new name, which will be announced shortly after closing, and remains headquartered at the “Creative Campus” in Monheim am Rhein, Germany.

Deal Team

Wolfgang Kazmierowski

Managing Director
Germany

Edward de Stigter

Director
Germany

“I am confident that Paragon is the perfect match to drive the development of Innere Medizin going forward. I thank the team for their valuable contributions at UCB and wish them the best of success for this new era as a fully independent organization”, said Johannes Leuchs, Head of Established Brands UCB.

“We appreciate UCB’s contribution to the success of Innere Medizin. Now, we are very enthusiastic and motivated to be joining the Paragon family and look forward to working with Paragon to drive the Innere Medizin business forward to new heights. This is an exciting opportunity for Innere Medizin and its employees.” said Karlheinz Gast, Managing Director of Innere Medizin.

Dr. Edin Hadzic, Managing Partner at Paragon commented: “We see great potential in the business of Innere Medizin and are looking forward to the upcoming next chapter. We have confidence in Karlheinz Gast and his team and are eager to further develop the company together.”

DC Advisory orchestrated a selected auction through its local presence in Europe, Asia and the US. “We are very pleased to have found a good home for Innere Medizin and wish Karlheinz Gast and his team all the best for the next growth phase of the Company together with Paragon”, said Dr. Wolfgang Kazmierowski, Managing Director at DC Advisory.